<DOC>
	<DOCNO>NCT00907504</DOCNO>
	<brief_summary>Gemcitabine cisplatin give together standard treatment option advance lung cancer patient . The purpose study assess life span long patient take investigational drug CP-751,871 combination gemcitabine cisplatin compare gemcitabine cisplatin alone . Considering 10 % rate drop-outs , 1,210 participant require order adequate sample size ( 1,100 evaluable patient ) power detect 30 % prolongation survival experimental arm .</brief_summary>
	<brief_title>Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>NonSmall Cell Lung Cancer ( NSCLC ) , advance , chemotherapynaive Male female &gt; 18 year Eastern Oncology Cooperative Group ( ECOG ) Performance Status ( PS ) 0 1 Adequate organ function Uncontrolled hypertension diabetes ; Pregnant female ; Symptomatic Central Nervous System ( CNS ) metastasis , requirement chronic corticosteroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>